Full name
BIOMED NEUROTECHNOLOGIE SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
47.74.Z - Retail sale of medical and orthopedic products
33.13.Z - Repair and maintenance of electronic and optical devices
47.41.Z - Retail trade
47.91.Z - Intermediary retail sale, non-specialized
47.99.Z - Retail trade
58.19.Z - Other publishing activities, excluding software publishing
77.39.Z - Rental and leasing of other machinery, equipment, and tangible assets, not elsewhere classified
82.30.Z - Activities related to organizing fairs, exhibitions, and congresses
85.59.B - Courses and training for acquiring knowledge, skills, and professional qualifications in non-school forms
86.90.E - Healthcare
2021 | 2022 | 2023 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Gross profit (loss) | 48,3 | 15,3 | 38,7 | 153,1 |
EBITDA | -42,7 | -44,7 | -52,3 | -17,1 |
Short time liabilities | 8 | 1,5 | 5,1 | 230,9 |
Equity capital | 153,8 | 166,1 | 197,5 | 18,9 |
Operating profit (EBIT) | -42,7 | -44,7 | -52,3 | -17,1 |
Assets | 161,8 | 167,7 | 202,6 | 20,8 |
Net profit (loss) | 39,2 | 12,4 | 31,4 | 153,1 |
Cash | 1,7 | 0,9 | 1,7 | 83,1 |
Net income from sale | 0 | 0 | 0 | 0 |
Liabilities and provisions for liabilities | 8 | 1,5 | 5,1 | 230,9 |
Working assets | 161,8 | 167,7 | 202,6 | 20,8 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | 25,5 | 7,5 | 15,9 | 8,4 |
Equity capital to total assets | 95 | 99,1 | 97,5 | -1,6 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 2 147 483 648 | 2 147 483 648 | 2 147 483 648 | 0 |
Current financial liquidity indicator | 20.163005828857422 | 109.61677551269531 | 40.01784133911133 | -69,6 |
Net dept to EBITDA | 0.040422335267066956 | 0.020615339279174805 | 0.032223887741565704 | 0 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane